20-Bio-A1 Biomaterials and Biocompatibility · December 2017
Nivaar worked solution (AI-drafted; not reviewed by a licensed engineer)
National Exams, December 2017 — 04-Bio-A1, Biomaterials and Biocompatibility (3 h, open book). Per the cover-page instructions, FIVE questions constitute a complete paper and the first five as they appear in the answer book are marked, each of equal value (20 marks); all SIX questions on this paper are solved below as a complete study resource.
Reference texts: Ratner, Hoffman, Schoen & Lemons, Biomaterials Science: An Introduction to Materials in Medicine (4th ed.); Saltzman, Drug Delivery: Engineering Principles for Drug Therapy; Enderle, Blanchard & Bronzino, Introduction to Biomedical Engineering (4th ed.).
Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.
The reconstruction below discusses the full eight-step sequence named in the question stem with a worked device example at each stage, which is the content the missing figure would have illustrated.
Take a permanently implanted, non-degradable device (e.g., a hip-replacement stem) as the running example through all eight stages.
1. Injury. The surgical procedure itself — incision, tissue dissection, and reaming of the bone canal to seat the stem — disrupts vasculature and tissue architecture at the implant site, independent of the implant material's own properties.
2. Blood–material interactions. Within seconds of blood contacting the implant surface, plasma proteins adsorb (fibrinogen, fibronectin, complement components, via the Vroman-effect competitive-adsorption process described in Question 1); this protein layer, not the bare material, is what the coagulation cascade, complement system, and platelets actually "see," and it is this layer that determines whether the response that follows is mild or severe.
3. Provisional matrix formation. Activated platelets and the coagulation cascade convert the adsorbed-protein layer and local plasma fibrinogen into a fibrin clot around the implant. This provisional matrix is not inert: it is a reservoir of platelet-derived and matrix-bound cytokines (PDGF, TGF-β) that chemotactically recruit the inflammatory and reparative cells of the following stages.
4. Acute inflammation. Neutrophils are the first inflammatory cells to arrive, within hours, attracted by the cytokines released from the provisional matrix and by complement fragments; they attempt to phagocytose and enzymatically/oxidatively degrade what they encounter (e.g., the visible neutrophil infiltrate seen histologically around a suture line in the first 24–48 h).
5. Chronic inflammation. If the material is not cleared — which, for a hip stem, it never will be — the acute neutrophil infiltrate is replaced over subsequent days by monocyte-derived macrophages and lymphocytes, which persist at the implant interface for as long as the material remains.
6. Granulation tissue formation. Fibroblasts and new capillary sprouts (angiogenesis) infiltrate the site, forming vascularized granulation tissue that begins to wall off and support the implant — the same tissue response classically observed around subcutaneous implant pockets.
7. Foreign body reaction. Macrophages that cannot phagocytose the implant (because it is too large, or has a rough/porous surface texture at a scale a single macrophage cannot engulf) fuse into multinucleated foreign body giant cells (FBGCs) at the implant–tissue interface; these cells continue to release reactive oxygen species and degradative enzymes directed at the surface, which for some polymers (e.g., certain polyurethanes) drives measurable surface degradation and, in wear-debris situations such as hip-implant polyethylene particles, this same FBGC response around wear debris is a major driver of aseptic loosening.
8. Fibrosis / capsule formation. Once the foreign body reaction stabilizes, fibroblasts recruited during granulation tissue formation deposit dense, largely avascular collagen around the implant, forming a fibrous capsule that isolates it from the surrounding tissue — the well-known endpoint seen clinically as capsular contracture around breast implants, and as the fibrous membrane found around a long-term, well-fixed (or, if thickened and painful, loosening) hip stem.
